Modified double disc synergy test to detect ESBL production in urinary isolates of Escherichia coli and Klebsiella pneumoniae

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 2, 2013, Pages 229-233

  Kaur, Jaspal ^a   Chopra, Shashi ^b   Sheevani, ^b   Mahajan, Gomty ^b  

^a Punjab Institute of Medical Sciences   (India)

^b NONE

Author keywords

Antimicrobial resistance; ESBL; Modified double disc synergy test

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DISK DIFFUSION; ENZYME SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MODIFIED DOUBLE DISC SYNERGY TEST; NONHUMAN;

EID: 84873935638     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/4619.2734     Document Type: Article

References (28)

1. Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended spectrum β-lactamases. Clin Infect Dis. 2006; 42: S153-S163.
2. Tsakris A, Poulou A, Themeli-Digalaki K, Voulgari E, Pittarais T, Sofianou D, et al. Use of boronic acid disk tests to detect extended spectrum β-lactamases in clinical isolates of KPC Carbapenemase possessing Enterobacteriaceae. J Clin Microbiol. 2009; 47:3420-26.
3. Mohanty S, Gaind R, Ranjan R, Deb M. Use of the cefepime-clavulanate ESBL test for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria. J Infect Dev Ctries. 2010; 4(1):024-29.
4. Chaudhary U, Aggarwal R. Extended spectrum β-lactamases (ESBL)-An emerging threat to clinical therapeutics. Indian J Med Microbiol. 2004; 22(2): 75-80.
5. Song W, Bae IK, Lee YN, Lee CH, Lee SH, Jeong SH. Detection of extended spectrum β-lactamases by using boronic-acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol. 2007; 45:1180-84.
6. Manchanda V, Singh NP. Occurrence and detection of AmpC β-lactamases among gram negative clinical isolates using a modified three-dimensional test at Guru Tegh Bhadur Hospital, Delhi, India. J Antimicrob Chemother. 2003; 51:415-18.
7. Thomson KS. Controversies about extended spectrum and AmpC β-lactamases. Emerg Infect Dis. 2001; 7:333-36.
8. Tzelepi E, Gaikkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended spectrum β-lactamases in clinical isolates of Enterobacter Cloacae and Enterobacter aerogenes. J Clin Microbiol. 2000; 38(2):542-46.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supple-ment M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA, (2009).
10. Paterson DL, Bonomo RA. Extended spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18(4)657-86.
11. Black JA, Moland ES, Thomson KS. AmpC Disk Test for detection of plasmid-mediated AmpC β-lactamase in Enterobacteriacae lacking chromosomal AmpC β-lactamase. J Clin Microbiol 2005; 43 (7):3110-13.
12. Dhillon RHP, Clark J. ESBLs: A Clear and present Danger. Crit Care Res Prac. 2012.
13. Grover SS, Sharma M, Chattopadhya D, Kapoor H, Pasha ST, Singh G. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin. J Infect. 2006; 53: 279-88.
14. Lal P, Kapil A, Das BK, Sood S. Occurrence of TEM and SHV gene in extended spectrum β-lactamases (ESBLs) producing Klebsiella spp. isolated from a tertiary care hospital. Indian J Med Res. 2007; 125: 173-8.
15. Goyal A, Prasad KN, Prasad A, Gupta S, Ghoshal U, Ayyagari A. Extended spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae and associated risk factors. Indian J Med Res. 2009; 129: 695-700.
16. MacKenzie FM, Miller FM CA, Gould IM. Comparison of screening methods for TEM and SHV derived ESBL detection. Clin Microbiol Infect. 2002; 8:715-24.
17. Paterson DL, Ko WC, Gottberg A, Cassellas JM, Mulazimoglu L, Klugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparentely susceptible organisms producing extended spectrum β-lactamases, Implications for the clinical microbiology laboratory. J Clin Microbiol. 2001; 39:2206-12.
18. Wong BA. Therapeutic challenges associated with extended spectrum β-lactamase producing E. coli and Klebsiella pneumoniae. Pharmacotherapy. 2001; 21:583-92.
19. Rice LB, Jao JD. Efficacy of different β-lactams against an ESBL producing Klebsiella pneumoniae strains in the rat intra abdominal abscess model. Antimicrob Agents Chemther. 1991; 35:1243-44.
20. Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended spectrum β-lactamases. Antimicrob Agents Chem. 1991; 35:164-69.
21. Paterson DL, Mulazimoglu L, Cassellas JM, Ko WC, Goossens H, von Gottberg A. Epidemiology of ciprofloxacin resistance and its relationship to extended spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000; 30(3):473-78.
22. Gupta V, Singla N, Chander J. Detection of ESBLs using third and fourth cephalosporins in double disc synergy test. Indian J Med Res. 2007; 126:486-87.
23. Parveen RM, Harish BN, Parija SC. Emerging carbepenem resistance among nosocomial isolates of Klebsiella pneumoniae in South India. Inter J Pharm Bio Sci. 2010; 1 (2):.
24. Gold HS, Moellering RC. Drug therapy: Antimicrobial-drug resistance. N Eng J Med. 1996; 335:1445-52.
25. Tzouvelekis LS, Vatapoulos AC, Katsanis G, Tzelepi E. Rare case of failure by an automated system to detect extended spectrum lactamase in a cephalosporin resistant Klebsiella pneumoniae isolate. J Clin Microbiol. 1999; 37(7):2388.
26. Kader AA, Angamuthu KK, Kamath KA, Zamon MN. Modified double-disc test for detection of extended spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae. Br J Biomed Sci. 2006; 63:51-54.
27. MKR Khan, SS Thukral, R Gaind, Evaluation of a Modified Double-Disc Synergy Test for Detection of Extended Spectrum β-Lactamases in Ampc β-Lactamase-Producing Proteus mirabilis. Indian J Med Microbiol. 2008; 26: 58-61.
28. Dhara M, Disha P, Sachin P, Manisha J, Seema B, Vegad MM. Comparison of various methods for the detection of extended spectrum β-lactamases in Klebsiella pneumoniae isolated from neonatal intensive care unit. National J Med Res. 2012; 2: 348-53.